| NCT Number | NCT06880861 |
| Lead Sponsor | Mayo Clinic |
| Conditions | Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm |
| Enrollment | 150 participants |
| Start Date | 2025-07-01 |
| Primary Completion | 2026-09-30 (estimated) |
| Study Completion | 2026-09-30 (estimated) |
| Updated on ClinicalTrials.gov | 2026-08-04 |